Literature DB >> 8694082

Transvaginal ultrasonography of pelvic masses: evaluation of B-mode technique and Doppler ultrasonography.

M Rehn1, K Lohmann, A Rempen.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate pelvic masses by B-mode and Doppler ultrasonography for identification of ovarian malignancies. STUDY
DESIGN: A previously described scoring system for pelvic masses was applied in 310 women, and the lesions were classified into four groups according to the ultrasonographic structure. Pulsatility index values of vessels within the tumor and the contralateral ovary and of both uterine arteries were determined.
RESULTS: A total of 259 masses were benign and 51 were malignant. The scoring system and classification into morphologic groups revealed similar sensitivity, specificity, and positive and negative predictive values. Intratumoral and opposite ovarian blood flow and ipsilateral and contralateral uterine blood flow did not differ in benign and malignant masses except in cases of benign lesions in postmenopausal women. In malignant lesions a lower pulsatility index (0.94 +/- 0.4) was measured than in benign lesions (1.06 +/- 0.4, p < 0.05), although a remarkable overlap was found.
CONCLUSION: The results suggest that further refinement of assessment of pelvic masses with Doppler ultrasonography is needed.

Entities:  

Mesh:

Year:  1996        PMID: 8694082     DOI: 10.1016/s0002-9378(96)70257-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  Quantitative multiparametric MRI of ovarian cancer.

Authors:  Jori S Carter; Joseph S Koopmeiners; Jessica E Kuehn-Hajder; Gregory J Metzger; Navneeth Lakkadi; Levi S Downs; Patrick J Bolan
Journal:  J Magn Reson Imaging       Date:  2013-04-04       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.